All regulations
Nonrulemaking
FDA
FDA-2025-N-1557
Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population; Public Meeting; Establishment of a Public Docket; Request for Comments
Documents
1
Comments
4,601
Description
OPEN
Key Dates
Comment Period OpensJun 16, 2025
Comment Period ClosesJul 17, 2025
Documents
Comment Statistics
Total Comments
4,601
Keywords
CDER
2025-289
Notice
Use of Orally Ingestible Unapproved
Prescription Drug Products Containing
Fluoride in the Pediatric Population
OPEN
Data from Regulations.gov